ResearcherSecond Affiliated Hospital of Chongqing Medical UniversityNo recent work listed
Zhihang Zhou
Matched on ORCID iD 0000-0003-1356-9872; OpenAlex author ID A5002918744.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 4
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 2
- Enhanced pentose phosphate pathway activity promotes pancreatic ductal adenocarcinoma progression via activating YAP/MMP1 axis under chronic acidosis. Last author DOI 10.7150/ijbs.69526↗
- Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling. Co-author DOI 10.18632/oncotarget.16911↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Jin-Wen Song · 2 shared papers, 2017–2022
- Paper Enhanced pentose phosphate pathway activity promotes pancreatic ductal adenocarcinoma progression via activating YAP/MM… DOI 10.7150/ijbs.69526↗
- Paper Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling. DOI 10.18632/oncotarget.16911↗
- Siyuan Chen · 1 shared paper, 2022
- Bo Ning · 1 shared paper, 2022
- Feng Gong · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.